申请人:Merck Patent GmbH
公开号:US06645991B1
公开(公告)日:2003-11-11
The invention describes novel compounds of the formula I which are biologically active as ligands of integrin &agr;v&bgr;3
X—Y—Z—R1—CH2—R2(R4)—CH2—CO—R5
in which X, Y, Z, R1, R2, R4 and R5 are as defined in claim 1, and their physiologically acceptable salts and solvates.
该发明描述了具有公式I的新化合物,它们作为整合素αvβ3的配体具有生物活性:X—Y—Z—R1—CH2—R2(R4)—CH2—CO—R5。其中,X、Y、Z、R1、R2、R4和R5的定义如权利要求书中所述,以及它们的生理上可接受的盐和溶剂化物。